Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 6 EP applications Eckard Kujath has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12756214

SUBSTITUTED 2-(CHROMAN-6-YLOXY)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/427, A61P 9/06, A61P 9/10, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Agent:
Paula De Souza, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759725

N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/4985, A61P 19/02, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP11306128

Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals

IPC classification:
A61K 31/427, A61P 9/06, A61P 9/10, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14710222

SUBSTITUTED CHROMAN-6-YLOXY-CYCLOALKANES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/353, A61P 9/00, C07D 311/60, C07D 405/12, C07D 407/12, C07D 407/14, C07D 409/12, C07D 413/12, C07D 417/12, C07D 417/14, C07F 9/09
Applicant:
Sanofi, S.A.
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Agent:
Paula De Souza, Sanofi
Status:
PATENT GRANTED
EP14711467

N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS

IPC classification:
A61K 31/437, A61K 31/52, A61P 9/00, A61P 19/02, C07D 471/04, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP11306179

N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals

IPC classification:
A61K 31/4985, A61P 19/02, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Eckard Kujath, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature